EXHIBIT 10.2
Harvard Apparatus Regenerative Technology, Inc.
SECURITIES PURCHASE AGREEMENT
This Securities Purchase Agreement (this “Agreement”) is dated as of September 11, 2026, between Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”), and Jerry (Junli) He, an individual and the Chief Executive Officer of the Company (the “Purchaser”).
WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act of 1933, as amended (the “Securities Act”) contained in Section 4(a)(2) thereof and/or Regulation D thereunder, the Company desires to issue and sell to Purchaser, and Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement.
…